Novo Nordisk announced that it has launched the NovoTwist needle for use with several Novo Nordisk pre-filled insulin delivery pen ... (8mm). For more information call (800) 727-6500 or visit www ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. In a Citizen Petition posted on ...

Denmark's Novo Nordisk <NOVOb.CO>, the ... Novo Nordisk says liraglutide better in study. By Reuters. August 9, 2007 9:10 PM UTC Updated June 21, 2007 Gelu Sulugiuc ...

Novo Nordisk will limit the supply of starter doses of Ozempic (0.25 mg) to help curb the initiation of new patients, the company said. During this period, the EMA has also recommended that ...

As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take center stage, Novo Nordisk’s efforts to ward off competition against its aging diabetes blockbuster Victoza have been ...

Diabetes drug Victoza, or liraglutide, is a first generation GLP-1, a class of treatments that has seen overwhelming demand. It has been on the FDA’s shortage list since 2023, and currently ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. Read more here.